Evidence map›Paper›PMID 27579369›Full record

ArticlemSphere

Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis.

I L Bartek, M J Reichlen, R W Honaker, R L Leistikow, E T Clambey, M S Scobey, A B Hinds, S E Born, C R Covey, M J Schurr and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Isolation and characterization of a novel mycobacteriophage Kashi-VT1 infectingFrontiers in cellular and infection microbiology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Bugs on Drugs: AMicroorganisms · 2022
    Article
  19. Rationally designed foldameric adjuvants enhance antibiotic efficacyMolecular systems design & engineering · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

I L BartekDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
M J ReichlenDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
R W HonakerDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
R L LeistikowDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
E T ClambeyDepartment of Anesthesiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
M S ScobeyDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
A B HindsDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
S E BornDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
C R CoveyDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
M J SchurrDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
A J LenaertsMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
M I VoskuilDepartment of Immunology and Microbiology, University of Colorado-Denver, School of Medicine, Aurora, Colorado, USA.
University of Colorado Denver · USColorado State University · US

Funding

The Mycobacterium Tuberculosis Dormancy ProgramR01AI061505 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VOSKUIL, MARTIN INUA · 2005 to 2015
$3.6M
NIAID NIH HHS R01 AI061505
6 · The paper itself

Abstract

Antibiotics target specific biosynthetic processes essential for bacterial growth. It is intriguing that several commonalities connect the bactericidal activity of seemingly disparate antibiotics, such as the numerous conditions that confer broad-spectrum antibiotic tolerance. Whether antibiotics kill in a manner unique to their specific targets or by a universal mechanism is a critical and contested subject. Herein, we demonstrate that the bactericidal activity of diverse antibiotics against Mycobacterium smegmatis and four evolutionarily divergent bacterial pathogens was blocked by conditions that worked to maintain intracellular pH homeostasis. Single-cell pH analysis demonstrated that antibiotics increased the cytosolic pH of M. smegmatis, while conditions that promoted proton entry into the cytosol prevented intracellular alkalization and antibiotic killing. These findings led to a hypothesis that posits antibiotic lethality occurs when antibiotics obstruct ATP-consuming biosynthetic processes while metabolically driven proton efflux is sustained despite the loss of proton influx via ATP synthase. Consequently, without a concomitant reduction in respiratory proton efflux, cell death occurs due to intracellular alkalization. Our findings indicate the effects of antibiotics on pH homeostasis should be considered a potential mechanism contributing to antibiotic lethality. IMPORTANCE Since the discovery of antibiotics, mortality due to bacterial infection has decreased dramatically. However, infections from difficult to treat bacteria such as Mycobacterium tuberculosis and multidrug-resistant pathogens have been on the rise. An understanding of the cascade of events that leads to cell death downstream of specific drug-target interactions is not well understood. We have discovered that killing by several classes of antibiotics was stopped by maintaining pH balance within the bacterial cell, consistent with a shared mechanism of antibiotic killing. Our findings suggest a mechanism of antibiotic killing that stems from the antibiotic's ability to increase the pH within bacterial cells by disrupting proton entry without affecting proton pumping out of cells. Knowledge of the core mechanism necessary for antibiotic killing could have a significant impact on the development of new lethal antibiotics and for the treatment of recalcitrant and drug-resistant pathogens.

Indexed as

Antibioticsbactericidal activitymycobacteriapH homeostasis

Identifiers

PMID27579369
PMCPMC4999920
OpenAlexW2510327419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.